The Patent Finder

Neurostimulation in a Neural Fulcrum Zone for the Treatment of Chronic Cardiac Dysfunction

LivaNova USA, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 14/224,922, filed Mar 25, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,669,220Neurostimulation in a Neural Fulcrum Zone for the Treatment of Chronic Cardiac Dysfunction
In force
 · High confidence
LivaNova USA, Inc.In force
High confidence
US 10,300,284Neurostimulation in a Neural Fulcrum Zone for the Treatment of Chronic Cardiac Dysfunction
In force
 · Low confidence
LivaNova USA, Inc.In force
Low confidence
US 11,738,199Neurostimulation in a Neural Fulcrum Zone for the Treatment of Chronic Cardiac Dysfunction
In force
 · High confidence
LivaNova USA, Inc.In force
High confidence
US 9,409,024Neurostimulation in a Neural Fulcrum Zone for the Treatment of Chronic Cardiac Dysfunction
In force
 · High confidence
LivaNova USA, Inc.In force
High confidence
US 11,077,304Neurostimulation in a Neural Fulcrum Zone for the Treatment of Chronic Cardiac Dysfunction
In force
 · High confidence
LivaNova USA, Inc.In force
High confidence
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited